Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Black Diamond Therapeutics (BDTX) Return on Sales (2025)

Black Diamond Therapeutics' Return on Sales history spans 1 years, with the latest figure at 0.24% for Q4 2025.

  • For Q4 2025, Return on Sales changed N/A year-over-year to 0.24%; the TTM value through Dec 2025 reached 0.24%, changed N/A, while the annual FY2025 figure was 0.24%, N/A changed from the prior year.
  • Return on Sales reached 0.24% in Q4 2025 per BDTX's latest filing, up from 0.22% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 0.79% in Q1 2025 to a low of 0.11% in Q2 2025.